Fibrinolysis in disease molecular and hemovascular aspects of fibrinolysis edited by Pia Glas-Greenwalt.
Detalles de publicación: Boca Raton, Fla. CRC Press c1996.Descripción: 279 p. ill. 28 cmISBN:- 0849369398 (alk. paper)
- 616.1/57 20
- RB145 .F527 1996
- WH 310 F4442 1995
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Libro | Biblioteca de Mayagüez Colección General mb | RB145 .F527 1996 (Navegar estantería(Abre debajo)) | Disponible | 50000002091576 |
Descripciones mejoradas de Syndetics:
Fibrinolysis in Disease reviews the state of the art of basic and clinical aspects of the fibrinolytic enzyme system. The text, authored by outstanding and internationally known investigators, is presented in two books.
The Malignant Process, Interventions in Thrombogenic Mechanisms, and Novel Treatment Modalities discusses the molecular biology of the system's key components and their fundamental roles in a variety of thrombotic and metabolic disorders. Molecular and Hemovascular Aspects of Fybrinolysis presents the latest findings and concepts of the association between plasminogen activator (u-PA) overexpression and abnormal growth regulation in a variety of solid tumors and in leukemia. One chapter deals with various successful interventions in thrombogenic mechanisms, ranging from exercise and diet to anticoagulants and direct and indirect thrombolytic agents. It concludes with a projection of exciting, novel treatment modalities in thrombotic and malignant diseases.
Includes bibliographical references and index.
Tabla de contenidos provista por Syndetics
- Pia of Molecular and Hemovascular Aspects:Molecular Biology of the Chief Regulators of the Fibrinolytic/Proteolytic Enzyme Systems
- Gene Expression and Function:Tissue-Type Plasminogen Activator
- Type Plasminogen Activator
- Plasminogen Activator Inhibitor-I
- The Cellular Receptor for u-PA (u-PAR)
- The Role of the Plasminogen Activation
Notas de autor provistas por Syndetics
Pia Glas-Greenwalt, M.D., is Director of the Fibrinolysis/Special Coagulation Laboratory at the Good Samaritan Hospital and affiliated with the Department of Internal Medicine at the University of Cincinnati Medical Center, Cincinnati, Ohio. She received her M.D. degree from the Eberhard Karl University School of Medicine in Tübingen, Germany (1961) and training in biochemistry at the James F. Mitchell Foundation, Institute for Medical Research, in Washington, D.C., where she was senior investigator from 1970 to 1975. Prior to joining the College of Medicine in Cincinnati, she was head of coagulation at the National Naval Medical Center, Bethesda, Maryland (1975 to 1979).